This is a critical milestone. Two therapeutic antibodies are now in the clinic with more on the way. These drugs can be available in time for Fall under an EUA. We must prioritize manufacturing these at scale needed to have sufficient supply for a Fall/Winter resurgence in Covid. https://t.co/O2B6Eww9kH

— Scott Gottlieb, MD (@ScottGottliebMD) June 11, 2020